RETICULOENDOTHELIAL DYSFUNCTION

RETICULOENDOTHELIAL DYSFUNCTION was reported 10 times

RETICULOENDOTHELIAL DYSFUNCTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nucleoside Analog Antifungal [EPC] 1 0.0007
1 Lipid-based Polyene Antifungal [EPC] 1 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Polyene Antifungal [EPC] 1 0.0000
4 Purine Antimetabolite [EPC] 1 0.0000
5 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
6 Azole Antifungal [EPC] 1 0.0000
7 Alkylating Drug [EPC] 1 0.0000
8 Corticosteroid [EPC] 5 0.0000
9 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
10 Tumor Necrosis Factor Blocker [EPC] 1 0.0000